FDA Approved: VABOMERE — Supplemental Application (Melinta Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for VABOMERE (meropenem-vaborbactam) from Melinta Therapeutics to modify/expand its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection

Drugs mentioned

• VABOMERE (MEROPENEM-VABORBACTAM)

Snippet

SUPPL AP for VABOMERE (MEROPENEM-VABORBACTAM)